TEMPE, Ariz., July 31, 2008 (PRIME NEWSWIRE) -- OrthoLogic Corp. (Nasdaq:OLGC) announced today that it will release financial and operating results for the second quarter ending June 30, 2008, on Thursday, August 7, 2008.
Management will host a conference call and webcast on Thursday, August 7, 2008 at 4:30 pm EDT (3:30 pm CDT, 2:30 pm MDT, 1:30 pm PDT). The call may be accessed at 800-437-3848 (domestic), 719-457-2089 (international), or by logging onto the Investors section of the Company's website, http://investor.orthologic.com.
A replay will be available beginning August 7, 2008 at 7:30 pm EDT until midnight August 9, 2008 and may be accessed at 888-203-1112 (domestic) or 719-457-0820 (international) with replay passcode 1607047.
About OrthoLogic
OrthoLogic is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. The Company is focused on development and commercialization of two product platforms: AZX100 and Chrysalin(r) (rusalatide acetate or TP508). AZX100 is a novel synthetic 24-amino acid peptide, one of a new class of compounds in the field of smooth muscle relaxation and fibrosis. Based on its demonstrated effects in pre-clinical models, AZX100 is currently being evaluated for commercially significant medical applications such as the treatment of pulmonary disease, the prevention of hypertrophic and keloid scarring and intimal hyperplasia. OrthoLogic has an exclusive worldwide license to AZX100. Chrysalin, the Company's novel synthetic 23-amino acid peptide, has been proven in multiple pre-clinical and clinical models to stimulate cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues. It is currently being evaluated in disorders that involve vascular endothelial dysfunction. The Company owns exclusive worldwide rights to Chrysalin.
OrthoLogic's corporate headquarters are in Tempe, Arizona. For more information, please visit the Company's website: www.orthologic.com.